ResiDUBs: A deubiquitinating enzyme-based prognostic model identifies UBXN1 driving sorafenib resistance in liver cancer

International Immunopharmacology 2026

View at publisher

Authors: Manqi Li, Yuxin Xie, Jinrui Wei, Lichuan Wu

DOI: 10.1016/j.intimp.2026.116290

Cited by: 0

References: 62

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis Ubiquitin and proteasome pathways Cancer-related molecular mechanisms research

References 62